Compare Stocks

Date Range: 

 LeMaitre VascularOrthoPediatricsMiMedx GroupCryoLifeAtrion
SymbolNASDAQ:LMATNASDAQ:KIDSNASDAQ:MDXGNYSE:CRYNASDAQ:ATRI
Price Information
Current Price$55.28$65.37$12.39$27.06$639.75
50-Day Moving Average$56.74$61.53$11.52$28.00$614.10
52-Week Low$27.91$38.01$5.32$16.13$567.00
52-Week High$64.50$68.00$13.02$32.34$745.00
MarketRank™
Overall Score2.72.32.22.02.0
Analysis Score2.31.53.52.30.0
Community Score4.94.45.04.74.1
Dividend Score1.70.00.00.02.5
Ownership Score3.35.01.72.53.3
Earnings & Valuation Score1.30.60.60.60.0
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyN/A
Consensus Price Target$62.33$69.67$21.50$32.00N/A
% Upside from Price Target12.76% upside6.57% upside73.53% upside18.26% upsideN/A
Trade Information
Market Cap$1.14 billion$1.29 billion$1.39 billion$1.06 billion$1.17 billion
Beta1.310.681.641.520.08
Average Volume167,53666,070476,551123,8145,289
Sales & Book Value
Annual Revenue$129.37 million$71.08 million$248.23 million$253.23 million$147.59 million
Price / Sales8.8118.085.594.187.93
Cashflow$1.47 per shareN/AN/A$0.79 per share$23.80 per share
Price / Cash37.58N/AN/A34.4626.88
Book Value$9.02 per share$12.01 per shareN/A$7.72 per share$129.63 per share
Price / Book6.135.443.514.94
Profitability
Net Income$21.22 million$-32,940,000.00$-49,280,000.00$-16,680,000.00$32.12 million
EPS$1.04($1.27)($0.77)$0.25N/A
Trailing P/E Ratio39.77N/AN/AN/A37.92
Forward P/E Ratio36.61N/AN/A82.00
P/E Growth4.04N/AN/AN/AN/A
Net Margins19.12%-50.38%-35.25%-4.15%21.61%
Return on Equity (ROE)16.51%-10.06%-1,262.51%2.39%12.94%
Return on Assets (ROA)11.41%-7.43%-45.91%0.94%11.69%
Dividend
Annual Payout$0.44N/AN/AN/A$7.00
Dividend Yield0.80%N/AN/AN/A1.09%
Three-Year Dividend Growth72.73%N/AN/AN/A46.67%
Payout Ratio42.31%N/AN/AN/AN/A
Years of Consecutive Dividend Growth1 YearsN/AN/AN/A17 Years
Debt
Debt-to-Equity Ratio0.10%N/AN/A1.02%N/A
Current Ratio4.19%4.15%2.71%4.04%11.13%
Quick Ratio2.11%2.64%2.50%2.74%6.54%
Ownership Information
Institutional Ownership Percentage86.67%74.37%42.21%82.87%65.35%
Insider Ownership Percentage14.10%30.30%19.80%4.50%22.02%
Miscellaneous
Employees3861167351,200636
Shares Outstanding20.61 million19.66 million111.93 million39.10 million1.83 million
Next Earnings Date11/4/2021 (Estimated)8/5/2021 (Confirmed)11/3/2021 (Estimated)11/3/2021 (Estimated)8/5/2021 (Estimated)
OptionableOptionableNot OptionableOptionableOptionableNot Optionable
SourceHeadline
Vapotherm (NYSE:VAPO) versus Atrion (NASDAQ:ATRI) Head-To-Head ReviewVapotherm (NYSE:VAPO) versus Atrion (NASDAQ:ATRI) Head-To-Head Review
americanbankingnews.com - July 30 at 1:24 PM
Elkem Silicones opens new research & innovation center in FranceElkem Silicones opens new research & innovation center in France
rubbernews.com - July 16 at 1:53 PM
Elkem Silicones opens new research & innovation centre in FranceElkem Silicones opens new research & innovation centre in France
european-rubber-journal.com - July 15 at 7:17 AM
Atrion (NASDAQ:ATRI) Is Reinvesting At Lower Rates Of ReturnAtrion (NASDAQ:ATRI) Is Reinvesting At Lower Rates Of Return
finance.yahoo.com - July 15 at 7:17 AM
Comparing Neuronetics (NASDAQ:STIM) and Atrion (NASDAQ:ATRI)Comparing Neuronetics (NASDAQ:STIM) and Atrion (NASDAQ:ATRI)
americanbankingnews.com - July 11 at 9:14 PM
Elkem Silicones Opens New ATRiON Research And Innovation Center In FranceElkem Silicones Opens New ATRiON Research And Innovation Center In France
textileworld.com - July 6 at 3:22 PM
Atrion Corporation (NASDAQ:ATRI) Stocks Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?Atrion Corporation (NASDAQ:ATRI) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?
nasdaq.com - June 20 at 9:37 AM
Only Four Days Left To Cash In On Atrions (NASDAQ:ATRI) DividendOnly Four Days Left To Cash In On Atrion's (NASDAQ:ATRI) Dividend
finance.yahoo.com - June 9 at 8:34 AM
Inflation Device Market Insights by Emerging Trends, Future Growth, Revenue Analysis, Demand Forecast Till 2024Inflation Device Market Insights by Emerging Trends, Future Growth, Revenue Analysis, Demand Forecast Till 2024
marketwatch.com - May 27 at 5:27 PM
Atrion Stock Is Estimated To Be Fairly ValuedAtrion Stock Is Estimated To Be Fairly Valued
ca.finance.yahoo.com - May 17 at 7:30 PM
Most Shareholders Will Probably Find That The Compensation For Atrion Corporations (NASDAQ:ATRI) CEO Is ReasonableMost Shareholders Will Probably Find That The Compensation For Atrion Corporation's (NASDAQ:ATRI) CEO Is Reasonable
nasdaq.com - May 15 at 2:12 PM
Why We Think Atrion Corporations (NASDAQ:ATRI) CEO Compensation Is Not Excessive At AllWhy We Think Atrion Corporation's (NASDAQ:ATRI) CEO Compensation Is Not Excessive At All
finance.yahoo.com - May 15 at 9:12 AM
Atrion: Q1 Earnings Snapshot | Raleigh News & ObserverAtrion: Q1 Earnings Snapshot | Raleigh News & Observer
newsobserver.com - May 11 at 2:53 PM
Atrion: Q1 Earnings SnapshotAtrion: Q1 Earnings Snapshot
sfgate.com - May 10 at 11:19 PM
Atrion (NASDAQ:ATRI) Shareholders Booked A 62% Gain In The Last Five YearsAtrion (NASDAQ:ATRI) Shareholders Booked A 62% Gain In The Last Five Years
nasdaq.com - April 12 at 9:14 AM
The Atrion (NASDAQ:ATRI) Share Price Is Up 62% And Shareholders Are Holding OnThe Atrion (NASDAQ:ATRI) Share Price Is Up 62% And Shareholders Are Holding On
finance.yahoo.com - April 12 at 9:14 AM
Atrion Stock Appears To Be Fairly ValuedAtrion Stock Appears To Be Fairly Valued
finance.yahoo.com - March 28 at 8:41 PM
Inflation Devices Market Size and Share with Future Insights, Top Manufacturers, Applications, Sales, Size, Types and Competitors by 2021 to 2025Inflation Devices Market Size and Share with Future Insights, Top Manufacturers, Applications, Sales, Size, Types and Competitors by 2021 to 2025
marketwatch.com - March 16 at 7:53 AM
Atrion Corporation (NASDAQ:ATRI) Goes Ex-Dividend SoonAtrion Corporation (NASDAQ:ATRI) Goes Ex-Dividend Soon
nasdaq.com - March 7 at 1:12 PM
Atrion Corporation (NASDAQ:ATRI) Pays A US$1.75 Dividend In Just Four DaysAtrion Corporation (NASDAQ:ATRI) Pays A US$1.75 Dividend In Just Four Days
finance.yahoo.com - March 7 at 8:11 AM
Do Institutions Own Atrion Corporation (NASDAQ:ATRI) Shares?Do Institutions Own Atrion Corporation (NASDAQ:ATRI) Shares?
finance.yahoo.com - February 27 at 8:29 AM
Atrion: 4Q Earnings Snapshot | Raleigh News & ObserverAtrion: 4Q Earnings Snapshot | Raleigh News & Observer
newsobserver.com - February 26 at 10:28 PM
Atrion Reports Results for Fourth Quarter and Full Year 2020Atrion Reports Results for Fourth Quarter and Full Year 2020
finance.yahoo.com - February 26 at 10:28 PM
Cardiac Surgical Devices Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast 2020 to 2027Cardiac Surgical Devices Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast 2020 to 2027
marketwatch.com - February 25 at 10:29 AM
Inflation Device Market Global Forecasts to 2024 by Display Type, Capacity, Applications, End Use Industry, Leading Key Players, Emerging TrendsInflation Device Market Global Forecasts to 2024 by Display Type, Capacity, Applications, End Use Industry, Leading Key Players, Emerging Trends
marketwatch.com - February 24 at 7:07 PM
DateCompanyBrokerageAction
8/3/2021LeMaitre VascularRoth Capital
Boost Price Target
7/30/2021LeMaitre VascularBarrington Research
Boost Price Target
7/30/2021CryoLifeMorgan Stanley
Boost Price Target
7/30/2021CryoLifeNeedham & Company LLC
Boost Price Target
7/26/2021MiMedx GroupNorthland Securities
Initiated Coverage
7/15/2021CryoLifeMorgan Stanley
Initiated Coverage
6/14/2021OrthoPediatricsNeedham & Company LLC
Boost Price Target
5/7/2021OrthoPediatricsTruist Securities
Boost Price Target
5/7/2021OrthoPediatricsTruist
Boost Price Target
5/7/2021OrthoPediatricsJMP Securities
Boost Price Target
5/6/2021OrthoPediatricsPiper Sandler
Reiterated Rating
5/6/2021CryoLifeNeedham & Company LLC
Boost Price Target
5/4/2021LeMaitre VascularRoth Capital
Boost Price Target
4/30/2021LeMaitre VascularLake Street Capital
Boost Price Target
4/30/2021LeMaitre VascularBarrington Research
Boost Price Target
4/30/2021CryoLifeNeedham & Company LLC
Boost Price Target
4/19/2021OrthoPediatricsTruist Securities
Boost Price Target
4/19/2021OrthoPediatricsTruist
Boost Price Target
4/6/2021OrthoPediatricsPiper Sandler
Boost Price Target
3/19/2021MiMedx GroupHC Wainwright
Initiated Coverage
3/2/2021LeMaitre VascularRoth Capital
Reiterated Rating
2/26/2021LeMaitre VascularBarrington Research
Boost Price Target
2/12/2021LeMaitre VascularKeyCorp
Initiated Coverage
2/12/2021CryoLifeNeedham & Company LLC
Boost Price Target
11/5/2020CryoLifeNeedham & Company LLC
Lower Price Target
10/30/2020LeMaitre VascularRoth Capital
Boost Price Target
10/30/2020LeMaitre VascularBarrington Research
Boost Price Target
10/7/2020OrthoPediatricsBTIG Research
Boost Price Target
9/3/2020CryoLifeNeedham & Company LLC
Reiterated Rating
9/2/2020CryoLifeOppenheimer
Reiterated Rating
8/5/2020OrthoPediatricsNeedham & Company LLC
Boost Price Target
7/30/2020CryoLifeOppenheimer
Reiterated Rating
7/24/2020LeMaitre VascularStifel Nicolaus
Boost Price Target
7/24/2020LeMaitre VascularCanaccord Genuity
Boost Price Target
7/24/2020LeMaitre VascularLake Street Capital
Boost Price Target
6/30/2020CryoLifeNeedham & Company LLC
Initiated Coverage
6/23/2020LeMaitre VascularCanaccord Genuity
Reiterated Rating
6/16/2020OrthoPediatricsStifel Nicolaus
Boost Price Target
6/8/2020OrthoPediatricsBTIG Research
Boost Price Target
5/14/2020OrthoPediatricsJMP Securities
Lower Price Target
5/6/2020OrthoPediatricsBTIG Research
Reiterated Rating
5/6/2020OrthoPediatricsNeedham & Company LLC
Boost Price Target
5/4/2020LeMaitre VascularStifel Nicolaus
Lower Price Target
5/4/2020LeMaitre VascularRoth Capital
Lower Price Target
5/1/2020LeMaitre VascularBarrington Research
Lower Price Target
5/1/2020CryoLifeLake Street Capital
Boost Price Target
4/14/2020LeMaitre VascularCanaccord Genuity
Lower Price Target
4/8/2020LeMaitre VascularSidoti
Lower Price Target
4/6/2020LeMaitre VascularLake Street Capital
Lower Price Target
4/3/2020OrthoPediatricsBTIG Research
Lower Price Target
4/3/2020CryoLifeLake Street Capital
Reiterated Rating
4/2/2020OrthoPediatricsNeedham & Company LLC
Lower Price Target
4/2/2020CryoLifeOppenheimer
Lower Price Target
4/2/2020CryoLifeNeedham & Company LLC
Lower Price Target
3/16/2020LeMaitre VascularSidoti
Upgrade
3/8/2020OrthoPediatricsBTIG Research
Reiterated Rating
3/6/2020OrthoPediatricsStifel Nicolaus
Boost Price Target
2/24/2020LeMaitre VascularRoth Capital
Reiterated Rating
2/14/2020CryoLifeNeedham & Company LLC
Reiterated Rating
2/14/2020CryoLifeCanaccord Genuity
Downgrade
2/14/2020CryoLifeFirst Analysis
Downgrade
2/7/2020LeMaitre VascularBarrington Research
Reiterated Rating
1/29/2020CryoLifeNeedham & Company LLC
Boost Price Target
1/7/2020OrthoPediatricsSunTrust Banks
Initiated Coverage
12/16/2019OrthoPediatricsPiper Jaffray Companies
Boost Price Target
12/11/2019CryoLifeNeedham & Company LLC
Upgrade
11/8/2019OrthoPediatricsPiper Jaffray Companies
Boost Price Target
10/24/2019LeMaitre VascularLake Street Capital
Upgrade
10/24/2019LeMaitre VascularFirst Analysis
Downgrade
10/22/2019CryoLifeOppenheimer
Initiated Coverage
7/31/2019CryoLifeCanaccord Genuity
Set Price Target
6/19/2019OrthoPediatricsNeedham & Company LLC
Initiated Coverage
5/12/2019CryoLifeNeedham & Company LLC
Reiterated Rating
5/10/2019OrthoPediatricsBTIG Research
Reiterated Rating
5/1/2019CryoLifeNeedham & Company LLC
Reiterated Rating
5/1/2019CryoLifeCanaccord Genuity
Reiterated Rating
4/29/2019OrthoPediatricsBTIG Research
Reiterated Rating
(Data available from 8/4/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.